Max Healthcare Reports Strong Quarterly Sales Amid Rising Interest Expenses and Debt Concerns
Max Healthcare Institute's financial results for the quarter ending December 2024 show notable growth in net sales, operating profit, and profits before and after tax, all reaching five-quarter highs. However, challenges include a declining operating profit to interest ratio, rising interest expenses, and a peak debt-equity ratio, indicating potential liquidity concerns.
Max Healthcare Institute has recently reported its financial results for the quarter ending December 2024, revealing a complex picture of performance within the Hospital & Healthcare Services industry. The company achieved net sales of Rs 1,868.31 crore, marking a significant growth of 24.4% compared to the average of the previous four quarters. This figure represents the highest quarterly sales recorded in the last five quarters, indicating a positive near-term sales trend.Operating profit also reached a peak of Rs 499.13 crore, alongside a profit before tax of Rs 349.20 crore and a profit after tax of Rs 295.73 crore, all reflecting the highest figures in the same five-quarter span. These metrics suggest a robust operational performance in the near term.
Conversely, the financial results highlight some challenges for Max Healthcare. The operating profit to interest ratio has fallen to its lowest point in five quarters at 9.53 times, indicating potential difficulties in managing interest payments. Additionally, the company has seen a significant rise in interest expenses, now at Rs 52.39 crore, which is the highest in the last five quarters. The debt-equity ratio has also reached its peak at 0.20 times, suggesting increased borrowing to support operations, which may impact liquidity. Furthermore, the debtors turnover ratio has declined to 11.36 times, indicating a slower pace in settling debts.
Overall, these results have led to an adjustment in evaluation for Max Healthcare.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
